Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia
暂无分享,去创建一个
H. Kantarjian | M. Routbort | K. Patel | F. Ravandi | C. Dinardo | R. Kanagal-Shamanna | L. Medeiros | C. Yin | D. Sui | P. Wei | J. Jorgensen | Sa A. Wang | R. Luthra | S. Loghavi | G. Tang | Z. Zuo | Zhenya Tang | C. Ok